The latest clinical trial results for Medtronic's ($MDT) insertable cardiac monitor show that it's
effective at detecting atrial fibrillation at an even higher rate than found in
a previous study.
...combines the expertise of three research groups at the University of Sheffield: Rehabilitation and Assistive Technology Group (RAT Group), the Centre for Assistive Technology and Connected Healthcare (CATCH) and the Telehealth and Care Technologies theme of CLAHRC YH (http://clahrc-yh.nihr.ac.uk/)
No comments:
Post a Comment